Treatment alternatives for sleep-disordered breathing in the pediatric population

Current Opinion in Pulmonary Medicine

Volumn 14, Issue 6, 2008, Pages 551-558

  Halbower, Ann C ^a   McGinley, Brian M ^b   Smith, Philip L ^c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

Adenotonsillectomy; Continuous positive airway pressure; Nasal cannula; Obesity; Obstructive sleep apnea; Pediatric; Sleep disordered breathing; Transnasal insufflation; Treatment

Indexed keywords

CAFFEINE; LEPTIN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MIRTAZAPINE; MODAFINIL; PROTRIPTYLINE; STEROID;

ADENOTONSILLECTOMY; AIRWAY RESISTANCE; ALTERNATIVE MEDICINE; ASTHMA; ATTENTION DEFICIT DISORDER; BARIATRIC SURGERY; BEHAVIOR DISORDER; BLOOD GAS; BRAIN FUNCTION; BRAIN INJURY; BRAIN NERVE CELL; CARDIOVASCULAR RISK; CLINICAL EXAMINATION; COMORBIDITY; CRANIOFACIAL MALFORMATION; CRANIOFACIAL SURGERY; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; EARLY DIAGNOSIS; ECONOMIC ASPECT; ELECTROMYOGRAPHY; ENZYME REGULATION; GASTROESOPHAGEAL REFLUX; HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOTHYROIDISM; HYPOXEMIA; INTELLECTUAL IMPAIRMENT; LEARNING DISORDER; LIPID METABOLISM; MEMORY DISORDER; METABOLIC SYNDROME X; MORBIDITY; NERVE CELL LESION; NOSE CONGESTION; NOSE OBSTRUCTION; NOSE SEPTUM; NOSE SURGERY; OBESITY; OXYGEN THERAPY; PEDIATRICS; POSITIVE END EXPIRATORY PRESSURE; QUALITY OF LIFE; REVIEW; SEDATION; SIDE EFFECT; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING; SOCIAL ASPECT; SOMNOLENCE; STOMACH DISTENSION; THYROID DISEASE; TRACHEOSTOMY; WEIGHT GAIN; WEIGHT REDUCTION;

ADENOIDECTOMY; ADOLESCENT; CHILD; CHILD, PRESCHOOL; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; LEUKOTRIENE ANTAGONISTS; SLEEP APNEA SYNDROMES; TONSILLECTOMY;

EID: 55149120450     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3283130f80     Document Type: Review

References (84)

1. Chervin RD, Ruzicka DL, Giordani BJ, et al. Sleep-disordered breathing, behavior, and cognition in children before and after adenotonsillectomy. Pediatrics 2006; 117:e769-e778.
2. Huang YS, Guilleminault C, Li HY, et al. Attention-deficit/ hyperactivity disorder with obstructive sleep apnea: a treatment outcome study. Sleep Med 2007; 8:18-30. Children with ADHD were found to have mild SDB, and some daytime symptoms (including attention span) and Test of Variables of Attention (TOVA) subscales (impulse control, response time, and total ADHD score) improved more after surgical treatment than with treatment with methylphenidate.
3. Rhodes SK, Shimoda KC, Waid LR, et al. Neurocognitive deficits in morbidly obese children with obstructive sleep apnea. J Pediatr 1995; 127:741-744.
4. Blunden S, Lushington K, Kennedy D, et al. Behavior and neurocognitive performance in children aged 5-10 years who snore compared to controls. J Clin Exp Neuropsychol 2000; 22:554-568.
5. Gozal D, Kheirandish-Gozal L. Neurocognitive and behavioral morbidity in children with sleep disorders. Curr Opin Pulm Med 2007; 13:505-509.
6. Halbower AC, Degaonkar M, Barker PB, et al. Childhood obstructive sleep apnea associates with neuropsychological deficits and neuronal brain injury. PLoS Med 2006; 3:e301.
7. Gozal D, Capdevila OS, Kheirandish-Gozal L. Metabolic alterations and systemic inflammation in obstructive sleep apnea among nonobese and obese prepubertal children. Am J Respir Crit Care Med 2008; 177:1142-1149. OSA induces insulin resistance in obese children. There were significant improvements in lipid profiles, C-reactive protein, and apolipoprotein B after adenotonsillectomy in both obese and nonobese children, suggesting a pathogenic role for SDB in lipid homeostasis and systemic inflammation independent of the degree of adiposity.
8. Baldassari CM, Mitchell RB, Schubert C, Rudnlck EF. Pediatric obstructive sleep apnea and quality of life: a meta-analysis. Otolaryngol Head Neck Surg 2008; 138:265-273. Pediatric OSA has a significant impact on QOL. QOL in pediatric OSA is similar to that of children with juvenile rheumatoid arthritis. Large improvements in QOL occur after adenotonsillectomy, and these findings are maintained in the long term.
9. Li HY, Huang YS, Chen NH, et al. Impact of adenotonsillectomy on behavior in children with sleep-disordered breathing. Laryngoscope 2006; 116:1142-1147.
10. Garetz SL Behavior, cognition, and quality of life after adenotonsillectomy for pediatric sleep-disordered breathing: summary of the literature. Otolaryngol Head Neck Surg 2008; 138:319-326.
11. Li AM, Chan MH, Yin J, et al. C-reactive protein in children with obstructive sleep apnea and the effects of treatment. Pediatr Pulmonol 2008; 43:34-40.
12. Kheirandish-Gozal L, Capdevila OS, Tauman R, Gozal D. Plasma C-reactive protein in nonobese children with obstructive sleep apnea before and after adenotonsillectomy. J Clin Sleep Med 2006; 2:301-304.
13. Yamamoto H, Teramoto S, Yamaguchi Y, Ouchi Y. Effect of nasal continuous positive airway pressure treatment on plasma adrenomedullin levels in patients with obstructive sleep apnea syndrome: roles of nocturnal hypoxia and oxidant stress. Hypertens Res 2007; 30:1065-1076.
14. Mitchell RB, Kelly J. Outcomes and quality of life following adenotonsillectomy for sleep-disordered breathing in children. ORL J Otorhinolaryngol Relat Spec 2007; 69:345-348.
15. Gozal D. Sleep-disordered breathing and school performance in children. Pediatrics 1998; 102:616-620.
16. Antczak J, Popp R, Hajak G, et al. Positron emission tomography findings in obstructive sleep apnea patients with residual sleepiness treated with continuous positive airway pressure. J Physiol Pharmacol 2007; 58 (Suppl 5):25-35.
17. McGinley BM, Schwartz AR, Schneider H, et al. Upper airway neuromuscular compensation during sleep is defective in obstructive sleep apnea. J Appl Physiol 2008; 105:197-205. This study demonstrates the supposition that neuromuscular responses protect individuals without sleep apnea from developing upper airway obstruction during sleep.
18. American Thoracic Society. Standards and indications for cardiopulmonary sleep studies in children. Am J Respir Crit Care Med 1996; 153:866-878.
19. Guilleminault C, Huang YS, Glamann C, et al. Adenotonsillectomy and obstructive sleep apnea in children: a prospective survey. Otolaryngol Head Neck Surg 2007; 136:169-175. Of 199 children with OSA who were treated with adenotonsillectomy, 94 still had abnormal sleep recordings. A high Mallampati score, retro-position of mandible, enlargement of nasal inferior turbinates, and deviated septum were significantly associated with persistence of abnormal polysomnography.
20. Guimaraes CV, Kalra M, Donnelly LF, et al. The frequency of lingual tonsil enlargement in obese children. AJR Am J Roentgenol 2008; 190:973-975. Obese children have a high frequency of enlargement of the lingual tonsils with a significantly higher prevalence in those with previous tonsillectomy. Enlarged lingual tonsils may play a role in the pathogenesis of obstructive sleep apnea in obese children.
21. Patil SP, Schneider H, Marx JJ, et al. Neuromechanical control of upper airway patency during sleep. J Appl Physiol 2007; 102:547-556.
22. Fregosi RF, Quan SF, Morgan WL, et al. Pharyngeal critical pressure in children with mild sleep-disordered breathing. J Appl Physiol 2006; 101:734-739.
23. Marcus CL, Katz ES, Lutz J, et al. Upper airway dynamic responses in children with the obstructive sleep apnea syndrome. Pediatr Res 2005; 57:99-107.
24. Guilleminault C, Huang YS, Kirisoglu C, Chan A. Is obstructive sleep apnea syndrome a neurological disorder? A continuous positive airway pressure follow-up study. Ann Neural 2005; 58:880-887.
25. Punjabi NM, Polotsky VY. Disorders of glucose metabolism in sleep apnea. J Appl Physiol 2005; 99:1998-2007.
26. Polotsky VY, Li J, Punjabi NM, et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 2003; 552 (Pt 1):253-264.
27. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287:356-359.
28. Redline S, Storfer-Isser A, Rosen CL, et al. Association between metabolic syndrome and sleep-disordered breathing in adolescents. Am J Respir Crit Care Med 2007; 176:401-408.
29. Friedman JM, Halaas JL Leptin and the regulation of body weight in mammals. Nature 1998; 395:763-770.
30. Tankersley C, Kleeberger S, Russ B, et al. Modified control of breathing in genetically obese (ob/ob) mice. J Appl Physiol 1996; 81:716-723.
31. Polotsky VY, Smaldone MC, Scharf MT, et al. Impact of interrupted leptin pathways on ventilatory control. J Appl Physiol 2004; 96:991-998.
32. Nieminen P, Tolonen U, Lopponen H. Snoring and obstructive sleep apnea in children - a 6-month follow-up study. Arch Otolaryngol Head Neck Surg 2000; 126:481-486.
33. Suen JS, Arnold JE, Brooks LJ. Adenotonsillectomy for treatment of obstructive sleep apnea in children. Arch Otolaryngol Head Neck Surg 1995; 121:525-530.
34. Brietzke SE, Gallagher D. The effectiveness of tonsillectomy and adenoidectomy in the treatment of pediatric obstructive sleep apnea/hypopnea syndrome: a meta-analysis. Otolaryngol Head Neck Surg 2006; 134:979-984.
35. Tauman R, Gulliver TE, Krishna J, et al. Persistence of obstructive sleep apnea syndrome in children after adenotonsillectomy. J Pediatr 2006; 149:803-808.
36. Lofstrand-Tidestrom B, Hultcrantz E. The development of snoring and sleep related breathing distress from 4 to 6 years in a cohort of Swedish children, Int J Pediatr Otorhinolaryngol 2007; 71:1025-1033.
37. Mitchell RB. Adenotonsillectomy for obstructive sleep apnea in children: outcome evaluated by pre and postoperative polysomnography. Laryngoscope 2007; 117:1844-1854.
38. O'Brien LM, Sitha S, Baur LA, Waters KA. Obesity increases the risk for persisting obstructive sleep apnea after treatment in children. Int J Pediatr Otorhinolaryngol 2006; 70:1555-1560.
39. Mitchell RB, Kelly J. Outcome of adenotonsillectomy for obstructive sleep apnea in obese and normal-weight children. Otolaryngol Head Neck Surg 2007; 137:43-48.
40. Koempel JA, Solares CA, Koltai PJ. The evolution of tonsil surgery and rethinking the surgical approach to obstructive sleep-disordered breathing in children. J Laryngol Otol 2006; 120:993-1000.
41. Sargi Z, Younis RT. Pediatric obstructive sleep apnea: current management. ORL J Otorhinolaryngol Relat Spec 2007; 69:340-344.
42. Sanders JC, King MA, Mitchell RB, Kelly JP. Perioperative complications of adenotonsillectomy in children with obstructive sleep apnea syndrome. Anesth Analg 2006; 103:1115-1121.
43. Brown KA, Laferriere A, Lakheeram I, Moss IR. Recurrent hypoxemia in children is associated with increased analgesic sensitivity to opiates. Anesthesiology 2006; 105:665-669.
44. Brown KA, Laferriere A, Moss IR. Recurrent hypoxemia in young children with obstructive sleep apnea is associated with reduced opioid requirement for analgesia. Anesthesiology 2004; 100:806-810.
45. Pirelli P, Saponara M, Guilleminault C. Rapid maxillary expansion in children with obstructive sleep apnea syndrome. Sleep 2004; 27:761-766.
46. Villa MP, Malagola C, Pagani J, et al. Rapid maxillary expansion in children with obstructive sleep apnea syndrome: 12-month follow-up. Sleep Med 2007; 8:128-134. The rapid maxillary expander device is an effective and nonsurgical approach to treatment of some children with SDB.
47. Ow AT, Cheung LK. Meta-analysis of mandibular distraction osteogenesis: clinical applications and functional outcomes. Plast Reconstr Surg 2008; 121:54e-69e.
48. Lin SY, Halbower AC, Tunkel DE, Vanderkolk C. Relief of upper airway obstruction with mandibular distraction surgery: long-term quantitative results in young children. Arch Otolaryngol Head Neck Surg 2006; 132:437-441.
49. Kohler M, Bloch KE, Stradling JR. The role of the nose in the pathogenesis of obstructive sleep apnoea and snoring. Eur Respir J 2007; 30:1208-1215.
50. Ferris BG, Mead J, Opie LH. Partitioning of respiratory flow resistance in man. J Appl Physiol 1964; 19:653-658.
51. Wilhoit SC, Suratt PM. Effect of nasal obstruction on upper airway muscle activation in normal subjects. Chest 1987; 92:1053-1055.
52. Basner RC, Simon PM, Schwartzstein RM, et al. Breathing route influences upper airway muscle activity in awake normal adults. J Appl Physiol 1989; 66:1766-1771.
53. Rappai M, Collop N, Kemp S, deShazo R. The nose and sleep-disordered breathing: what we know and what we do not know. Chest 2003; 124:2309-2323.
54. McNamara JA. Influence of respiratory pattern on craniofacial growth. Angle Orthod 1981; 51:269-300.
55. Guilleminault C, Lee JH, Chan A. Pediatric obstructive sleep apnea syndrome. Arch Pediatr Adolesc Med 2005; 159:775-785.
56. Smith PL, O'Donnell CP, Allan L, Schwarte AR. A physiologic comparison of nasal and oral positive airway pressure. Chest 2003; 123:689-694.
57. Kribbs NB, Pack Al, Kline LR, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 1993; 147:887-895.
58. Marcus CL, Rosen G, Ward SL, et al. Adherence to and effectiveness of positive airway pressure therapy in children with obstructive sleep apnea. Pediatrics 2006; 117:e442-e451.
59. Slifer KJ, Kruglak D, Benore E, et al. Behavioral training for increasing preschool children's adherence with positive airway pressure: a preliminary study. Behav Sleep Med 2007; 5:147-175. A case report and review of cognitive-behavioral therapy techniques used by psychologists for desensitization and CPAP training.
60. Smith PL, Wise RA, Gold AR, et al. Upper airway pressure-flow relationships in obstructive sleep apnea. J Appl Physiol 1988; 64:789-795. One of the first studies demonstrating that the upper airway functions as a Starling resistor with a collapsible segment in the oropharynx. The finding of unobstructed flow with nasal CPAP, but disrupted airway flow, using full face masks was lost on both device companies manufacturing and clinicians using the full face mask. A must-read for clinicians treating patients with OSA.
61. Bach JR, Niranjan V, Weaver B. Spinal muscular atrophy type 1 : a noninvasive respiratory management approach. Chest 2000; 117:1100-1105.
62. Guilleminault C, Nino-Murcia G, Heldt G, et al. Alternative treatment to tracheostomy in obstructive sleep apnea syndrome: nasal continuous positive airway pressure in young children. Pediatrics 1986; 78:797-802.
63. Edwards EA, Hsiao K, Nixon GM. Paediatric home ventilatory support: the Auckland experience. J Paediatr Child Health 2005; 41:652-658.
64. Institute of Medicine. Field MJ, Tilson H, editors. Safe medical devices for children: committee on postmarket surveillance of pediatreic medical devices, 1st ed. Washington, DC: The National Academies Press; 2006.
65. Halbower AC, Ishman SL, McGinley BM. Childhood obstructive sleep-disordered breathing: a clinical update and discussion of technological innovations and challenges. Chest 2007; 132:2030-2041.
66. McGinley BM, Patil SP, Kirkness JP, et al. A nasal cannula can be used to treat obstructive sleep apnea. Am J Respir Grit Care Med 2007; 176:194-200. A high-flow, heated, humidified, low pressure delivery of air via cannula that demonstrates resolution of apnea in adults. Development of a device such as this for home use may be a novel CPAP alternative with improved adherence.
67. He J, Kryger MH, Zorick FJ, et al. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 1988; 94:9-14.
68. Doherty LS, Kiely JL, Swan V, McNicholas WT. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005; 127:2076-2084.
69. Suratt PM, McTier RF, Findley LI, et al. Changes in breathing and the pharynx after weight loss in obstructive sleep apnea. Chest 1987; 92: 631-637.
70. Quan SF, O'Connor GT, Quan JS, et al. Association of physical activity with sleep-disordered breathing. Sleep Breath 2007; 11:149-157.
71. Barbeau P, Johnson MH, Howe CA, et al. Ten months of exercise improves general and visceral adiposity, bone, and fitness in black girls. Obesity (Silver Spring) 2007; 15:2077-2085.
72. Davis CL, Tkacz J, Gregoski M, et al. Aerobic exercise and snoring in overweight children: a randomized controlled trial. Obesity (Silver Spring) 2006; 14:1985-1991.
73. Al Qahtani AR. Laparoscopic adjustable gastric banding in adolescent: safety and efficacy. J Pediatr Surg 2007; 42:894-897.
74. Carley DW, Olopade C, Ruigt GS, Radulovacki M. Efficacy of mirtazapine in obstructive sleep apnea syndrome. Sleep 2007; 30:35-41.
75. Goldbart AD, Goldman JL, Veling MC, Gozal D. Leukotriene modifier therapy for mild sleep-disordered breathing in children. Am J Respir Crit Care Med 2005; 172:364-370.
76. Goldbart AD, Goldman JL, Li RC, et al. Differential expression of cysteinyl leukotriene receptors 1 and 2 in tonsils of children with obstructive sleep apnea syndrome or recurrent infection. Chest 2004; 126:13-18.
77. Hirshkowitz M, Black JE, Wesnes K, et al. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome. Respir Med 2007; 101:616-627.
78. Bardwell WA, Norman D, Ancoli-lIsrael S, et al. Effects of 2-week nocturnal oxygen supplementation and continuous positive airway pressure treatment on psychological symptoms in patients with obstructive sleep apnea: a randomized placebo-controlled study. Behav Sleep Med 2007; 5:21-38. Supplemental oxygen provided significant reductions in general psychological symptoms compared with placebo, and depression improved with oxygen but not CPAP or placebo, indicating that hypoxemia plays an important role in some neuropsychological symptoms occurring with SDB.
79. Gold AR, Schwartz AR, Bleecker ER, Smith PL. The effect of chronic nocturnal oxygen administration upon sleep apnea. Am Rev Respir Dis 1986; 134:925-929.
80. Simakajornboon N, Beckerman RC, Mack C, et al. Effect of supplemental oxygen on sleep architecture and cardiorespiratory events in preterm infants. Pediatrics 2002; 110:884-888.
81. Aljadeff G, Gozal D, Bailey-Wahl SL, et al. Effects of overnight supplemental oxygen in obstructive sleep apnea in children. Am J Respir Grit Care Med 1996; 153:51-55.
82. Barros JR, Becker HM, Pinto JA. Evaluation of atopy among mouth-breathing pediatric patients referred for treatment to a tertiary care center. J Pediatr (Rio J) 2006; 82:458-464.
83. Jha A, Shartna SK, Tandon N, et al. Thyroxine replacement therapy reverses sleep-disordered breathing in patients with primary hypothyroidism. Sleep Med 2006; 7:55-61.
84. Friedman M, Gurpinar B, Lin HC, et al. Impact of treatment of gastroesophageal reflux on obstructive sleep apnea-hypopnea syndrome. Ann Otol Rhinol Laryngol 2007; 116:805-811.